Skip to content

Preterm Birth Cohort Study in Guangzhou

Preterm Birth Cohort Study in Guangzhou

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03668327
Acronym
PBCSG
Enrollment
5000
Registered
2018-09-12
Start date
2012-02-01
Completion date
2038-12-31
Last updated
2024-02-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Host and Microbiome, Immune Development, Neurodevelopment, Preterm Birth

Keywords

Preterm, Cohort, Early development, Child

Brief summary

The Preterm Birth Cohort Study in Guangzhou (PBCSG) aims to explore the impact of genetic and environmental factors including life styles on preterm birth, to examine the interaction effect between these factors, and to follow up the short-term and long-term outcomes of preterm childrens.

Detailed description

Preterm birth has become the leading cause of neonatal death and the second leading cause of death among children under five years of age. Preterm childrens are more susceptible to adverse health problems including brain injury and neurodevelopment delay, and are at risk of chronic diseases which could impair the health status and life quality later in life. However, the causes of preterm birth is still not clear, and there are no effective prediction and preventive strategies. The Preterm Birth Cohort Study in Guangzhou (PBCSG) will collect the epidemiological,clinical information and biological specimens including maternal blood,cord blood, placenta, children's blood and stool samples of preterm childrens and their mothers. More importantly, childrens' health status, physical and neurodevelopment will be followed up to late childhood and adolescence. The preterm birth cohort would help to explore the mechanism of preterm birth and to examine the short- and long-term influence of preterm birth on physical health and neurodevelopment of childrens.

Interventions

None listed

Sponsors

Guangzhou Women and Children's Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
No minimum to 18 Years
Healthy volunteers
Yes

Inclusion criteria

1. Born before 37 weeks of gestation 2. Born in Guangzhou Women and Children's Medical Center 3. Intended to remain in Guangzhou for more than 3 years

Exclusion criteria

1. Multiple birth 2. Stillbirth 3. With major congenital abnormalities

Design outcomes

Primary

MeasureTime frameDescription
Neurodevelopment at early childhoodAt age of 1 yearAssessed by using the Gesell Developmental Schedules, which include adaptive, gross motor, fine motor, language, and social function domains. Higher score in each domain is considered a better outcome, while no more than 85 is defined as suspected development retardation

Secondary

MeasureTime frameDescription
Height changes during childhood and adolescenceAt birth, age of 6 weeks, 6 months, 1 year, 3 years, 6 years, 12 years and 18 yearMeasured by nurses in clinic using a standard tool
Weight changes during childhood and adolescenceAt birth, age of 6 weeks, 6 months, 1 year, 3 years, 6 years, 12 years and 18 yearMeasured by nurses in clinic using a standard tool
Intelligence quotient of offspringAt age of 6 years oldAssessed by using Wechsler's Intelligence Scale for Children (WISC), which can generate a full scale intelligence quotient score and five primary index scores including verbal comprehension, visual spatial, fluid reasoning, working memory, and processing speed. Intelligence quotient ranges from 40 to 160,in which less than 70 is defined as mental retardation
Changes of body fat percentage during early childhoodAt age of 3 years, 6 years, 12 years and 18 years oldAssessed by Dual Energy X-Ray Absorptiometry (defined as total mass of fat divided by total body mass)
Changes of bone density during early childhoodAt age of 3 years, 6 years, 12 years and 18 years oldAssessed by Dual Energy X-Ray Absorptiometry
Change of intestinal flora during early childhoodAt age of 6 weeks, 6 months, 1 year, 3 years, 6 years, 12 years and 18 years oldAssessed by analyses of stool samples

Countries

China

Contacts

Primary ContactXiu Qiu, MD,PhD
qxiu0161@163.com0086 20 38367160
Backup ContactYashu Kuang, Master
0086 20 38367159

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026